Ratings by Needham & Company (Ami Fadia)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/1/2022 Avadel Pharmaceuticals AVDL Maintain Buy
(Buy)
 
 
  Details
6/15/2022 Acadia Pharmaceuticals ACAD Maintain Hold
(N/A)
 
 
  Details
6/6/2022 Merus N.V. MRUS Maintain Buy
(Buy)
 
 
  Details
4/19/2022 Acadia Pharmaceuticals ACAD Maintain Hold
(Hold)
 
 
  Details
4/13/2022 Intra-Cellular Therapies ITCI Maintain Buy
(Buy)
 
 
  Details
4/12/2022 Bicycle Therapeutics BCYC Maintain Buy
(Buy)
 
 
  Details
4/12/2022 Harmony Biosciences Holdings Inc. HRMY Maintain Buy
(Buy)
 
 
  Details
4/12/2022 Avadel Pharmaceuticals AVDL Maintain Buy
(Buy)
 
 
  Details
4/8/2022 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
4/4/2022 Acadia Pharmaceuticals ACAD Maintain Hold
(Hold)
 
 
  Details
3/29/2022 Intra-Cellular Therapies ITCI Maintain Buy
(Buy)
 
 
  Details
3/28/2022 Jazz Pharmaceuticals JAZZ Maintain Buy
(Buy)
 
 
  Details
3/9/2022 Acadia Pharmaceuticals ACAD Maintain Hold
(Hold)
 
 
  Details
3/2/2022 Jazz Pharmaceuticals JAZZ Maintain Buy
(Buy)
 
 
  Details
3/2/2022 Bicycle Therapeutics BCYC Maintain Buy
(Buy)
 
 
  Details
3/1/2022 Intra-Cellular Therapies ITCI Maintain Buy
(Buy)
 
 
  Details
3/1/2022 Acadia Pharmaceuticals ACAD Maintain Hold
(Hold)
 
 
  Details
3/1/2022 Merus N.V. MRUS Maintain Buy
(Buy)
 
 
  Details
2/28/2022 Harmony Biosciences Holdings Inc. HRMY Maintain Buy
(Buy)
 
 
  Details
2/25/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
2/24/2022 Sage Therapeutics SAGE Maintain Buy
(Buy)
 
 
  Details
2/22/2022 Avadel Pharmaceuticals AVDL Maintain Buy
(Buy)
 
 
  Details
2/16/2022 Sage Therapeutics SAGE Maintain Buy
(Buy)
 
 
  Details
2/15/2022 Seagen SGEN Maintain Buy
(Buy)
 
 
  Details
2/14/2022 Neurocrine Bio. NBIX Maintain Hold
(Hold)
 
 
  Details
2/11/2022 Neurocrine Bio. NBIX Maintain Hold
(Hold)
 
 
  Details
2/10/2022 Biogen BIIB Maintain Buy
(Buy)
 
 
  Details
2/10/2022 Merus N.V. MRUS New Coverage Buy
(N/A)
26.14
(22.33)
-14.58% Details
2/4/2022 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
2/3/2022 Biogen BIIB Maintain Buy
(Buy)
 
 
  Details
1/28/2022 Biogen BIIB Maintain Buy
(Buy)
 
 
  Details
1/18/2022 Sage Therapeutics SAGE Maintain Buy
(Buy)
 
 
  Details
1/13/2022 Harmony Biosciences Holdings Inc. HRMY Maintain Buy
(Buy)
 
 
  Details
1/12/2022 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
1/11/2022 Avadel Pharmaceuticals AVDL Maintain Buy
(N/A)
 
 
  Details
1/11/2022 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
1/6/2022 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/20/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
12/9/2021 Bicycle Therapeutics BCYC New Coverage Buy
(N/A)
56.00
(17.49)
-68.77% Details
12/6/2021 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
11/23/2021 Harmony Biosciences Holdings Inc. HRMY Maintain Buy
(N/A)
 
 
  Details
11/8/2021 Avadel Pharmaceuticals AVDL Maintain Buy
(N/A)
 
 
  Details
10/21/2021 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
10/20/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
10/19/2021 Biogen BIIB Maintain Buy
(N/A)
 
 
  Details
10/18/2021 Avadel Pharmaceuticals AVDL Maintain Buy
(N/A)
 
 
  Details
9/23/2021 Jazz Pharmaceuticals JAZZ New Coverage Buy
(N/A)
129.10
(158.58)
22.84% Details
9/23/2021 Avadel Pharmaceuticals AVDL New Coverage Buy
(N/A)
8.12
(2.57)
-68.35% Details
9/23/2021 Sage Therapeutics SAGE New Coverage Buy
(N/A)
45.23
(32.28)
-28.63% Details
9/23/2021 Intra-Cellular Therapies ITCI New Coverage Buy
(N/A)
37.18
(55.17)
48.39% Details
9/23/2021 Neurocrine Bio. NBIX New Coverage Hold
(N/A)
95.51
(99.25)
3.92% Details
9/23/2021 Biogen BIIB New Coverage Buy
(N/A)
295.54
(210.63)
-28.73% Details
9/23/2021 Acadia Pharmaceuticals ACAD New Coverage Hold
(N/A)
17.02
(14.37)
-15.57% Details
9/23/2021 Harmony Biosciences Holdings Inc. HRMY New Coverage Buy
(N/A)
38.61
(52.00)
34.68% Details